Certified by Founder
Lodge
SimBioSys, Inc.
start up
United States
- Chicago, Illinois
- 26/10/2021
- Series A
- $15,000,000
SimBioSys is a technology company on a mission to deploy Computational Oncology to transform decision making and patient experience in Cancer Care. By virtualizing cancer, clinicians and patients are empowered with a better understanding of the disease and can assess all available options computationally to truly individualize treatment.
- Industry Biotechnology Research
- Website https://www.simbiosys.com/
- LinkedIn https://www.linkedin.com/company/simbiosys-inc/
Niobium Microsystems | $23,000,000 | (Dec 10, 2025)
Corma | $4,069,327 | (Dec 10, 2025)
Scowtt | $12,000,000 | (Dec 10, 2025)
AnySignal | $24,000,000 | (Dec 10, 2025)
AllScale | $5,000,000 | (Dec 10, 2025)
CoreOps.AI | $3,500,000 | (Dec 10, 2025)
BON Credit | $3,500,000 | (Dec 10, 2025)
Opine | $5,000,000 | (Dec 10, 2025)
Rotostitch | $1,000,000 | (Dec 10, 2025)
Buildcheck | $5,900,000 | (Dec 10, 2025)
Diald AI | $3,750,000 | (Dec 10, 2025)
Tuhk Inc. | $6,000,000 | (Dec 10, 2025)